Rasayan.ai is an advanced AI-powered drug discovery platform designed to accelerate the identification, design, and development of novel small molecules. By combining artificial intelligence, computational chemistry, and predictive modeling, the platform enables scientists to make faster, smarter, and more confident decisions throughout the drug discovery lifecycle.
From hit identification and lead optimization to toxicity prediction, retrosynthesis, route planning, impurity analysis, and degradation liability assessment, Rasayan.ai provides an integrated environment that empowers research teams to reduce risk, shorten development timelines, and improve R&D productivity.
Recognized globally for its predictive capabilities, Rasayan.ai helps pharmaceutical companies, biotechnology organizations, CROs, CDMOs, and research institutions leverage AI to drive innovation and accelerate the journey from discovery to development.
Key Capabilities:
AI-driven small molecule drug discovery
Retrosynthesis & route planning
Toxicity prediction and risk assessment
Predicted impurities analysis
Degradation liability assessment
Scientific intelligence and decision support
Faster lead optimization and candidate selection
Transforming the future of drug discovery through intelligent, data-driven science.
